Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biologically based modeling in toxicology research.

M E Andersen1, K Krishnan, R B Conolly

  • 1Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709.

Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic significance of circulating tumor DNA as a baseline or dynamic factor in advanced NSCLC without oncogenic drivers: A systematic review and meta-analysis.

Critical reviews in oncology/hematology·2026
Same author

On-site plant-wax biomarker analysis for assessing soil-organic-microbial degradation in archaeological contexts: A case study from Southern India.

iScience·2025
Same author

Seasonally resolved stratigraphy at Jwalapuram India shows regional surface warming after the Toba volcanic super-eruption.

PNAS nexus·2025
Same author

Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2024
Same author

Using available <i>in vitro</i> metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloroprene.

Frontiers in pharmacology·2023
Same author

Response to "letter concerning: Clewell (2019) incorporation of <i>in vitro</i> metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053).

Inhalation toxicology·2020

Biologically based modeling uses quantitative equations to predict chemical toxicity and guide research. This approach aids in understanding chemical disposition and toxic action, improving risk assessment accuracy.

Area of Science:

  • Toxicology
  • Computational Biology
  • Risk Assessment

Background:

  • Biologically based modeling quantifies mechanistic steps in chemical disposition and toxic action.
  • These models enable extrapolation across doses, routes, and species in risk assessment.
  • Their primary utility lies in expressing hypotheses about chemical interactions for research.

Purpose of the Study:

  • To examine progress in developing biologically based models for cancer induction by non-genotoxic carcinogens.
  • To detail strategies for integrating dosimetry, cytotoxicity, and carcinogenicity models.
  • To demonstrate the broad applicability of these modeling concepts to various chemicals and toxicity endpoints.

Main Methods:

  • Developing quantitative equations to represent mechanistic steps of chemical disposition.

Related Experiment Videos

  • Utilizing computer simulation to predict toxicological experiment outcomes.
  • Linking models for dosimetry, cytotoxicity, and carcinogenicity.

    • Main Results:

    • Progress in comprehensive biologically based models for non-genotoxic carcinogens is examined.
    • Strategies for integrating different model components are described.
    • The approach facilitates identification of data gaps for prioritizing research.

    Conclusions:

    • Biologically based modeling serves as a crucial research tool for understanding chemical toxicity.
    • The methods discussed can be applied to diverse toxic chemicals and endpoints beyond cancer.
    • This structured approach enhances quantitative risk assessment by addressing data limitations.